Clinical Trial Update: ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent [NA]

View source ↗

Summary

Update on the ALTERRA trial evaluating the SAPIEN 3 transcatheter heart valve with the Alterra Adaptive Prestent for pulmonary valve procedures; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Pulmonary Regurgitation
• Tetralogy of Fallot

Drugs mentioned

• SAPIEN 3 THV with Alterra Adaptive Prestent

Snippet

Sponsor: Edwards Lifesciences | Conditions: Pulmonary Disease, Transcatheter Pulmonary Valve Replacement (TPVR) | NA | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-08-08